Cumberland Pharmaceuticals Inc financial data

Symbol
CPIX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2525 West End Avenue, Suite 950, Nashville,, TN
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 129 % -19.7%
Quick Ratio 16.1 % -55.9%
Debt-to-equity 196 % +32.6%
Return On Equity -40.7 % -506%
Return On Assets -13.7 % -406%
Operating Margin -13.6 % +36.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14M shares -1.5%
Common Stock, Shares, Outstanding 14M shares -1.46%
Entity Public Float 12.1M USD -30.3%
Common Stock, Value, Issued 47.2M USD -0.73%
Weighted Average Number of Shares Outstanding, Basic 14.1M shares -1.57%
Weighted Average Number of Shares Outstanding, Diluted 14.1M shares -1.57%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 42M USD +16.7%
Revenue from Contract with Customer, Excluding Assessed Tax 36.8M USD -6.45%
Research and Development Expense 4.79M USD -19.9%
Selling and Marketing Expense 17.6M USD +2.86%
General and Administrative Expense 11.2M USD +4.84%
Costs and Expenses 47.6M USD +5.73%
Operating Income (Loss) -10.8M USD -90.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -10.8M USD -346%
Income Tax Expense (Benefit) 59.3K USD -14%
Net Income (Loss) Attributable to Parent -10.9M USD -348%
Earnings Per Share, Basic -0.77 USD/shares -353%
Earnings Per Share, Diluted -0.77 USD/shares -353%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 17.5M USD -5.64%
Accounts Receivable, after Allowance for Credit Loss, Current 11.3M USD -10.4%
Inventory, Net 4.51M USD -48%
Other Assets, Current 1.97M USD -47.3%
Assets, Current 35.2M USD -15.6%
Property, Plant and Equipment, Net 312K USD -17.3%
Operating Lease, Right-of-Use Asset 6.21M USD -7.49%
Goodwill 914K USD 0%
Other Assets, Noncurrent 2.83M USD +10.7%
Assets 76.7M USD -12.5%
Accounts Payable, Current 12.1M USD +11.5%
Employee-related Liabilities, Current 1.2M USD -16.9%
Accrued Liabilities, Current 13.6M USD -22.7%
Contract with Customer, Liability, Current 220K USD -64.1%
Liabilities, Current 31.1M USD +13.8%
Operating Lease, Liability, Noncurrent 5M USD -7.27%
Other Liabilities, Noncurrent 6.09M USD -5.65%
Liabilities 52.3M USD +0.35%
Retained Earnings (Accumulated Deficit) -22.1M USD -97.1%
Stockholders' Equity Attributable to Parent 24.8M USD -31.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 24.5M USD -31.4%
Liabilities and Equity 76.7M USD -12.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.14M USD -50.7%
Net Cash Provided by (Used in) Financing Activities 2.42M USD
Net Cash Provided by (Used in) Investing Activities -58.2K USD +66.6%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 14M shares -1.46%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 227K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 17.5M USD -5.64%
Deferred Tax Assets, Valuation Allowance 21.9M USD +1.45%
Deferred Tax Assets, Gross 23.4M USD +3.12%
Operating Lease, Liability 5.39M USD -5.84%
Payments to Acquire Property, Plant, and Equipment 41.6K USD -61.2%
Lessee, Operating Lease, Liability, to be Paid 8.49M USD -9.18%
Property, Plant and Equipment, Gross 2.61M USD +9.99%
Operating Lease, Liability, Current 392K USD +17.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 910K USD +8.83%
Lessee, Operating Lease, Liability, to be Paid, Year One 836K USD -3.15%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.1M USD -14.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 934K USD +2.67%
Preferred Stock, Shares Authorized 20M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 741K USD -20.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 7.83M USD +94.6%
Depreciation, Depletion and Amortization 1.15M USD -8.36%
Interest Expense 561K USD -16.1%